上海生物芯片有限公司 Shanghai Biochip Corporation (Sbc) company information, Employees & Contact Information

上海生物芯片有限公司成立于2001年8月，公司现有股东：上海科创集团、张江集团、中科院上海生科院、中科院上海微系统所、复旦大学、上海交大、南方人类基因组中心、瑞金医院和博星基因。 2003年2月，国家发展与改革委员会批准上海生物芯片有限公司建设和运行“生物芯片上海国家工程研究中心”项目并正式命名，项目总投资2.9亿元人民币。公司（中心）本着“科研创新、市场导向、以人为本”的价值理念，按照国家工程研究中心的建设目标要求，努力使公司形成集技术创新、成果转化、综合服务、人才培养于一体，具有国际先进水平的国家生物芯片产业化基地。公司（中心）位于上海浦东张江高科技园区生物医药产业基地，总占地4万平方米，建筑面积2万多平方米。 Shanghai Biochip Co., Ltd.（SBC） was founded in Aug. 2001. The existing shareholders of the company include universities, research institutes, hospitals and enterprises in China. In Feb. 2003, the National Development and Reform Commission authorized SBC to build up and operate the National Engineering Center for biochip at Shanghai project. SBC is located in the Biotech&Pharmaceutical Industrial Base at Zhangjiang High-tech Park in Shanghai, SBC owns more than 300 employees now. In accordance with company's development strategy and the construction requirements raised by National Development and Reform Commission for the National Engineering Center, SBC is committed to applying and promoting biotechnology development and products for life science research、health-care、 drug discovery and other fields. Through more than 10 years of construction and development, the technology innovation service system is established which is based on the core platforms of the biological sample bank, tissue chips, gene expression chips and the next-generation sequencing; The industrialized system which takes molecular medical diagnosis technology and product development as the core competitiveness has been set up; And three main business areas which include the services for research and drugs R&D, molecular medicine inspection services, and production and sales of molecular diagnostic product. SBC obeys the value idea of “Scientific innovation, Business orientation, Career development”, follows the construction requirements for the National Engineering Center, and strives to make the company an internationally-advanced national bio-chip industrialization base which integrates the function of technology innovation, achievements transformation, comprehensive service and personal training as a whole. What’s more, the company’s strategic goal is to be an innovative benchmark enterprise among the industry with an level internationally-advanced and has the capability of independent research and development. It would make a contribution to the goal of making Shanghai an influential technology innovation center and also contribute to the domestic field of biomedical science and technology innovation and industrialization in our country.